Back to News
quantum-computing

The Nasdaq's win streak, Netflix earnings, another AI pivot and more in Morning Squawk

CNBC Technology
Loading...
4 min read
0 likes
⚡ Quantum Brief
Netflix surpassed Q1 expectations, boosted by a $2.8B breakup fee from its terminated Warner Bros. Discovery deal, but shares dropped 10% premarket after co-founder Reed Hastings announced his June board departure. Quantum computing stocks surged over 50% this week, with IonQ and D-Wave leading gains, as Nvidia’s open-source AI models fueled optimism about quantum adoption, contrasting with declining chipmaker stocks despite strong earnings. Myseum’s AI pivot sent shares soaring 130%, mirroring Allbirds’ recent shift, though analysts warn such moves rarely succeed long-term, highlighting speculative retail investor behavior in volatile markets. A 10-day Israel-Lebanon ceasefire, brokered by the U.S., lifted stocks after Iran condemned prior attacks, easing geopolitical tensions and driving market gains in Thursday’s session. HHS may relax peptide regulations, potentially benefiting Hims & Hers, which acquired a peptide facility in 2025, though safety and efficacy concerns remain due to limited oversight and scientific data.
The Nasdaq's win streak, Netflix earnings, another AI pivot and more in Morning Squawk

Summarize this article with:

This is CNBC's Morning Squawk newsletter. Subscribe here to receive future editions in your inbox.Happy Friday. If you're already starting to think about how to maximize next year's tax return, my colleague Hayley Cuccinello breaks down how the wealthiest among us are preparing.Stock futures are rising this morning after a winning session.Here are five key things investors need to know to start the trading day:Stocks climbed higher in yesterday's session after President Donald Trump announced that Israel and Lebanon agreed to 10-day ceasefire, inviting leaders from both countries to the White House for peace talks. Iran had previous called Israeli attacks on Lebanon a violation of Tehran's own ceasefire with the U.S.Here's what to know:Netflix easily beat analyst expectations on both lines for the first quarter yesterday. The streaming giant saw a big jump in earnings per share thanks partly to the $2.8 billion breakup fee it received following the termination of its proposed Warner Bros. Discovery deal.The California-based company also announced a key leadership change: Chairman, co-founder and former CEO Reed Hastings will step down from Netflix's board after his term ends in June. Co-CEO Ted Sarandos wrote off the idea that Hastings' departure is tied to the WBD deal, calling Hastings a "big champion" for Netflix's bid for WBD's assets.Netflix shares tumbled around 10% in premarket trading.There's a tale of two sectors playing out in tech as the Nasdaq continues its big win streak.Quantum stocks have surged this week amid investor optimism that Nvidia's open-source artificial intelligence models will boost quantum computing adoption. IonQ and D-Wave Quantum shares have soared more than 50% just this week, while Quantum Computing and Rigetti Computing have climbed more than 30%.At the same time, shares of Taiwan Semiconductor and ASML sank despite strong earnings reports from both chip manufacturers. As CNBC's Katie Tarasov reports, their moves are the latest example of chipmaker stocks buckling under the weight of lofty expectations.CNBC's Morning Squawk recaps the biggest stories investors should know before the stock market opens, every weekday morning.Subscribe here to get access today.Allbirds isn't the only company unexpectedly pivoting to AI this week: Social media company Myseum announced that it is zeroing in on using AI agents for personalization on its platforms. Shares of the penny stock jumped about 130% in Thursday's session. While the company is changing its name to Myseum.AI, it said it will continue to trade under the MYSE ticker.The move comes after retail investors rushed into Allbirds' stock following its own announcement that it would shift its focus from shoes to AI. But as CNBC's Yun Li notes, history shows that this type of trade doesn't typically pan out well.Health and Human Services Secretary Robert F. Kennedy Jr. signaled this week that regulators could ease restrictions on peptides. That could be welcome news for Hims & Hers as it looks for its next growth driver after GLP-1s.As CNBC's Brandon Gomez reports, the telehealth company has been working on its peptide business for years, notably acquiring a California-based peptide facility in 2025. Peptides are controversial: Their production is largely unregulated and there's limited scientific data on the long-term safety or efficacy of their use. — CNBC's Hayley Cuccinello, Kevin Breuninger, Dan Mangan, Sean Conlon, Lisa Kailai Han, Greg Iacurci, Spencer Kimball, Lee Ying Shan, Lillian Rizzo, Samantha Subin, Katie Tarasov, Yun Li and Brandon Gomez contributed to this report.Davis Giangiulio assisted in the production of this newsletter. Josephine Rozzelle edited this edition.Got a confidential news tip? We want to hear from you.Sign up for free newsletters and get more CNBC delivered to your inboxGet this delivered to your inbox, and more info about our products and services.© 2026 Versant Media, LLC.

All Rights Reserved. A Versant Media Company. Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Data also provided by

Read Original

Source Information